XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Changes in Equity (Unaudited) - USD ($)
Common Stock [Member]
Subscription Receivable [Member]
Common Stock Subscribled [Member]
Additional Paid-in Capital [Member]
Statutory Reservel [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Noncontrolling Interest [Member]
Total
Beginning balance, value at Jun. 30, 2021 $ 7,881 $ (8,535,203) $ 41,105,806 $ 4,198,107 $ 8,661,071 $ (731,805) $ 672,349 $ 45,378,206
Beginning balance, shares at Jun. 30, 2021 7,881,482                
Stock issuance $ 292 5,511,203 1,969,708 7,481,203
Stock issuance, shares 291,775                
Issuance of common shares for convertible notes redemption $ 1,696 7,248,304 7,250,000
Issuance of common shares for convertible notes redemption, shares 1,695,877                
Beneficial conversion feature associated with convertible notes 361,252 361,252
Disposal of Ankang (1,072,667) (1,072,667)
Net income (loss) for the period (20,008,627) (25,199) (20,033,826)
Foreign currency translation gain (loss) 948,330 14,019 962,349
Ending balance, value at Mar. 31, 2022 $ 9,869 (3,024,000) 50,685,070 4,198,107 (11,347,556) 216,525 (411,498) 40,326,517
Ending balance, shares at Mar. 31, 2022 9,869,134                
Beginning balance, value at Dec. 31, 2021 $ 9,432 (3,024,000) 49,435,507 4,198,107 (8,454,972) 67,175 (396,807) 41,834,442
Beginning balance, shares at Dec. 31, 2021 9,431,707                
Stock issuance $ 437 1,249,563 1,250,000
Stock issuance, shares 437,427                
Net income (loss) for the period (2,892,584) (13,384) (2,905,968)
Foreign currency translation gain (loss) 149,350 (1,307) 148,043
Ending balance, value at Mar. 31, 2022 $ 9,869 (3,024,000) 50,685,070 4,198,107 (11,347,556) 216,525 (411,498) 40,326,517
Ending balance, shares at Mar. 31, 2022 9,869,134                
Beginning balance, value at Jun. 30, 2022 $ 10,984 (3,024,000) 52,998,924 4,198,107 (18,372,023) (2,100,756) (398,348) 33,312,888
Beginning balance, shares at Jun. 30, 2022 10,983,863                
Stock issuance $ 7,536 (148,362) 9,847,804 9,706,978
Stock issuance, shares 7,536,183                
Issuance of common shares for convertible notes redemption $ 813 826,824 827,637
Issuance of common shares for convertible notes redemption, shares 812,580                
Net income (loss) for the period (7,878,128) 53,312 (7,824,816)
Foreign currency translation gain (loss) (1,242,060) 245,305 (996,755)
Acquisition of Biowin   5,301,786 5,301,786
Proceeds received from investors for subscription of common stock 1,194,029 1,194,029
Common stock issued for management and employees $ 1,322 (650,000) 1,665,122 1,016,444
Common stock issued for management and employees, shares 1,322,222                
Common stock issued for services $ 10 29,990 30,000
Common stock issued for services, shares 10,000                
Ending balance, value at Mar. 31, 2023 $ 20,665 (3,822,362) 1,194,029 65,368,664 4,198,107 (26,250,151) (3,342,816) 5,202,055 42,568,191
Ending balance, shares at Mar. 31, 2023 20,664,848                
Beginning balance, value at Dec. 31, 2022 $ 19,657 (3,532,340) 63,985,227 4,198,107 (23,581,618) (3,268,590) (392,061) 37,428,382
Beginning balance, shares at Dec. 31, 2022 19,657,356                
Stock issuance 359,978 359,978
Issuance of common shares for convertible notes redemption $ 276 299,725 300,001
Issuance of common shares for convertible notes redemption, shares 275,270                
Net income (loss) for the period (2,668,533) 58,548 (2,609,985)
Foreign currency translation gain (loss) (74,226) 233,782 159,556
Acquisition of Biowin   5,301,786 5,301,786
Proceeds received from investors for subscription of common stock 1,194,029   1,194,029
Common stock issued for management and employees $ 722 (650,000)   1,053,722         404,444
Common stock issued for management and employees, shares 722,222                
Common stock issued for services $ 10 29,990 30,000
Common stock issued for services, shares 10,000                
Ending balance, value at Mar. 31, 2023 $ 20,665 $ (3,822,362) $ 1,194,029 $ 65,368,664 $ 4,198,107 $ (26,250,151) $ (3,342,816) $ 5,202,055 $ 42,568,191
Ending balance, shares at Mar. 31, 2023 20,664,848